LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes
- 31 May 2007
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 192 (1), 138-147
- https://doi.org/10.1016/j.atherosclerosis.2006.04.023
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDLBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications TrialDiabetes, 1995
- Apolipoprotein E phenotypes and plasma lipids in diabetic children and adolescentsEuropean Journal of Pediatrics, 1993
- Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.JCI Insight, 1991
- Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.JCI Insight, 1989
- Apolipoprotein E polymorphism and lipoproteins in insulin-treated diabetes mellitusAtherosclerosis, 1989
- Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.JCI Insight, 1980
- PLASMA LIPOPROTEIN CONVERSIONS: THE ORIGIN OF LOW‐DENSITY AND HIGH‐DENSITY LIPOPROTEINS *Annals of the New York Academy of Sciences, 1980
- TYPE-III HYPERLIPOPROTEINÆMIA ("REMNANT REMOVAL DISEASE"): Insight into the Pathogenetic MechanismThe Lancet, 1977